Share on PinterestSputnik V shows promise in post-registration trials in Russia.Photo credit: Natalia Kolesnikova/AFP via Getty ImagesFirstly, scientists at the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, devised a vaccine that elicits a robust immune response, with no serious side effects in humans. The last few weeks also saw the development of a…
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Sputnik V, Gamaleya National CenterTHE RUSSIAN DIRECT INVESTMENT FUND Latest coronavirus news as of 5 pm on 4 September Russia’s vaccine candidate produced antibody and T-cell responses in early-stage trial A preliminary trial of Russia’s coronavirus…
By Michael Le Page Denis Rebrikov says he will still move forward with gene-editing work to prevent heritable deafnessAndrey Rudakov/Bloomberg via Getty Russian biologist Denis Rebrikov has told New Scientist that he still plans to use CRISPR genome editing to prevent children inheriting deafness, despite a major international report out today saying it isn’t yet…
You don't have permission to access "http://www.medpagetoday.com/meetingcoverage/esc/122822" on this server. Reference #18.d494d817.1788149026.80a0b543 https://errors.edgesuite.net/18.d494d817.1788149026.80a0b543
Philip Friedman 3 min read MEN'S HEALTH IS 38 this year, and like any self-respecting guy in their mid-thirties, we're taking a beat to look back on some of the highlights over the three and a half decades we've been around, from the guys who've best exemplified strength over the years to some of our
11 min read AS A BRIGHT light flashes against a mustard yellow backdrop, 33-year-old actor Chase Stokes plays with the edges of a chunky sweater. First, he pulls on a sleeve, like he’s simply at home getting dressed, not on the last day of a long-ass press tour for the fifth and final season of
